• Bulletin of the Korean Chemical Society
• /
• 제31권8호
• /
• pp.2392-2394
• /
• 2010

• 한국미생물·생명공학회지
• /
• 제38권2호
• /
• pp.183-189
• /
• 2010

반추동물의 급성 산독증의 예방 및 치료제 개발 연구의 일환으로 100종의 네팔 식물추출물을 이용하여 미생물 유래의 $\alpha$-amylase 및 $\alpha$-glucosidase 저해 활성을 평가하였다. 그결과 Cedrus deodara(Roxb.) G. Don와 Myrica nagi Thunb.추출물에서 acarbose보다 강력한 $\alpha$-amylase 저해활성을 확인하였으며, 각각의 $IC_{50}$는 44.5, 47.5 및 $50.5\;{\mu}g/mL$로 확인되었다. 또한 고혈당 치료 효과가 보고된 Cleistocalyx operculatus(Roxb.) 추출물에서는 강력한 $\alpha$-amylase 저해활성 및 양호한 $\alpha$-glucosidase 저해 활성을 확인하였다. 최종 선정된 3종의 추출물은 1 mg/mL 농도까지 인간적혈구에 대한 용혈활성이 없었으며, $80^{\circ}C$, 또는 0.01N HCl 조건에서 60분간 처리시에 활성의 변화가 나타나지 않았으며, 특히 C. operculatus(Roxb.)와 M. nagi Thunb의 경우 산 처리시에 오히려 20% 정도의 저해활성의 증가가 나타났다. 이러한 결과는, 최종 선정된 3종의 추출물이 미생물 유래의 전분분해 효소의 저해를 통해 반추동물의 급성 산독증 예방 및 치료에 이용 가능함을 제시하고 있다.

• Biomolecules & Therapeutics
• /
• 제23권6호
• /
• pp.549-556
• /
• 2015

Consumption of herbal tea [flower buds of Cleistocalyx operculatus (Roxb.) Merr. et Perry (Myrtaceae)] is associated with health beneficial effects against multiple diseases including diabetes, asthma, and inflammatory bowel disease. Emerging evidences have reported that High mobility group box 1 (HMGB1) is considered as a key "late" proinflammatory factor by its unique secretion pattern in aforementioned diseases. Dimethyl cardamonin (2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone, DMC) is a major ingredient of C. operculatus flower buds. In this study, the anti-inflammatory effects of DMC and its underlying molecular mechanisms were investigated on lipopolysaccharide (LPS)-induced macrophages. DMC notably suppressed the mRNA expressions of TNF-${\alpha}$, IL-$1{\beta}$, IL-6, and HMGB1, and also markedly decreased their productions in a time- and dose-dependent manner. Intriguingly, DMC could notably reduce LPS-stimulated HMGB1 secretion and its nucleo-cytoplasmic translocation. Furthermore, DMC dose-dependently inhibited the activation of phosphatidylinositol 3-kinase (PI3K), phosphoinositide-dependent kinase 1 (PDK1), and protein kinase C alpha (PKC${\alpha}$). All these data demonstrated that DMC had anti-inflammatory effects through reducing both early (TNF-${\alpha}$, IL-$1{\beta}$, and IL-6) and late (HMGB1) cytokines expressions via interfering with the PI3K-PDK1-PKC${\alpha}$ signaling pathway.